NCT04840615 2024-02-02Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant MesotheliomaNational Institutes of Health Clinical Center (CC)Phase 1 Terminated2 enrolled 14 charts